European diabetes and cancer experts collaborate

Tuesday 4 October 2011

The European Multidisciplinary Cancer Congress included joint symposia on diabetes and cancer, part of an ongoing collaboration between European experts in the fields of cancer and diabetes. It has long been known that Type 2 diabetes is associated with increased risk of certain types of cancer, but more recently it also emerged that there may be a link between diabetes treatments such as glargine and increased cancer risk.


Further information

European Oncology Nursing Society
Avenue E. Mounier 83
B-1200 Brussels
Belgium
Tel: +32 (0)2 779 9923
Fax: +32 (0)2 779 9937
eons.secretariat@cancernurse.eu